Technoclone
Business Services · Austria · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Brunner St 67, Vienna, Vienna, 1230, Aus...Phone Number
+43 1863730Website
www.technoclone.comRevenue
$9.8 MillionIndustry
About Technoclone
Is Technoclone your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Technoclone has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Technoclone had a recent Job posting/layoffs
Check out if Technoclone is spiking on competitors!
Funding: Get notified immidiatlly once Technoclone has new funding data
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Technoclone launches new products
Technoclone, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Technoclone
Earning: See what the market has to say on Technoclone recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Technoclone as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Technoclone is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Technoclone is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Technoclone.
Technoclone Tech Stack
A closer look at the technologies used by Technoclone
Most Recent Scoops
Top Business Services Companies
Frequently Asked Questions Regarding Technoclone
Founded in 1987, Technoclone is a leading global producer of hemostasis diagnostic products. The company was the first worldwide to offer a complete set of monoclonal antibody-based ELISAs in the field of fibrinolysis and a novel patented system allowing the determination of activity and antigen in the same sample. The company holds more than ten i... Read More